are glp-1 covered by medicare Bridge Program Explained: Medications for Weight Loss Recent Trends in GLP-1 Use
Description
The CDSCO has just issued a clear advisory (dated March 11, 2026) directing all manufacturers, importers, and marketing authorization holders of GLP-1 receptor agonists (like semaglutide/Ozempic, tirzepatide/Mounjaro, etc.) to strictly avoid any promotional activities for these prescription-only drugs used in obesity management
BENEDICT Study Group
Loose or lax skin doesn't have to be a permanent reality
More on that in a minute
